Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin-II Blockade in Mitral Regurgitation
NCT00587470Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 1998
- Primary completion
- Aug 2001
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of candesartan in mitral regurgitation (MR), sponsored by Mayo Clinic. Started Aug 1998; status: completed.
02
Drugs
candesartan
03
Conditions
mitral regurgitation (MR)
Beyond the preview
Go deeper on NCT00587470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00587470.